| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.006 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.01 |